0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month FREE

[+] Author Affiliations

Section Editor: Walter W. Tunnessen, MD

More Author Information
Arch Pediatr Adolesc Med. 2001;155(2):192. doi:10.1001/archpedi.155.2.191.
Text Size: A A A
Published online

Figure 1. The left lower limb is longer and larger in circumference than the right limb.

Figure 2. An extensive nevus flammeus is present on the face, trunk, and right arm with a diffuse bluish discoloration of the lateral and posterior aspects of the right chest wall.

Figure 3. The pink and blue pigmentary changes involve large portions of the skin surface.

Phakomatosis pigmentovascularis (PPV) is a rare disorder characterized by the association of cutaneous vascular and melanocytic lesions. The pigmentary changes usually involve more than 50% of the skin surface and persist throughout life.1

CUTANEOUS FEATURES

Nevus flammeus, a constant feature in PPV, is a congenital vascular malformation consisting of dilated thin-walled capillaries and small veins. The port-wine stain of Sturge-Weber syndrome is a nevus flammeus; however, in PPV the vascular malformation is much more extensive in distribution. The most common melanocytic lesion associated with PPV is the slate gray to blue discoloration typical of Mongolian spots but more extensive in distribution. Other pigmentary changes include nevus spilus, a café-au-lait macule studded with small, dark, raised nevi; nevus pigmentosus et verrucosus, an epidermal nevus that may have raised, wartlike components; and nevus anemicus, macules or patches that are pale, reflecting vasoconstriction of underlying vessels.

Phakomatosis pigmentovascularis has been classified into 4 types: I, characterized by nevus flammeus and nevus pigmentosus et verrucosus; II, nevus flammeus and blue spots with or without nevus anemicus; III, nevus flammeus and nevus spilus with or without nevus anemicus; and IV, nevus flammeus, blue spots, and nevus spilus, with or without nevus anemicus.1 Additionally, the 4 types are divided into subtypes a and b. Subtype a has cutaneous disease only, while subtype b has cutaneous and systemic features.1

ASSOCIATED SYSTEMIC FEATURES

Children with PPV may have systemic features associated with Sturge-Weber and Klippel-Trenaunay syndromes. In Sturge-Weber syndrome, which almost always features a port-wine stain in the distribution of the first branch of the trigeminal nerve, associated systemic problems may include glaucoma and central nervous system leptomeningeal vascular malformations leading to seizures, cerebral atrophy, and mental retardation. Klippel-Trenaunay syndrome is characterized asymmetric overgrowth of a limb and soft tissues associated with vascular malformations, nevus flammeus, and varicosities. Internal hemangiomas and vascular malformations have also been described in this syndrome.

Other systemic anomalies described with PPV include iris hamartomas, scleral pigmentary changes, primary lymphedema, renal angiomas, moyamoya disease, scoliosis, malignant colonic polyposis, hypoplastic larynx, multiple granular cell tumors, and selective IgA deficiency.14

PATHOGENESIS AND MANAGEMENT

Although the cause of PPV is unknown, it has been proposed that the combination of vascular and pigmentary anomalies arise as a result of a genetic concept called the twin-spotting phenomenon.5,6 In this phenomenon, there is double heterozygosity with the recessive vascular mutation on 1 chromosome and the pigmentary mutation on the homologous chromosome. During embryogenesis, somatic recombination or crossing-over occurs between the homologous chromosomes, resulting in 2 different cell populations, each being homozygous for either allele.

There is no specific treatment for this disorder. Recognition of possible underlying systemic and local anomalies and complications dictates management.

Accepted for publication June 28, 1999

Drs Narchi and Santos, employed by Saudi Aramco during the time this infant was studied and when the article was written, acknowledge the use of Saudi Aramco Medical Services Organization facilities.

Reprints: Hassib Narchi, MD, Paediatric Department, Sandwell General Hospital, Lyndon, West Bromwich, West Midlands B 71 4HJ, United Kingdom.

Di Landro  ATadini  GLMarchesi  LCainelli  T Phakomatosis pigmentovascularis: a new case with renal angiomas and some considerations about the classification. Pediatr Dermatol. 1999;1625- 30
Link to Article
Du  LCDelaporte  ECatteau  BDestee  APiette  F Phacomatosis pigmentovascularis type II. Eur J Dermatol. 1998;8569- 572
Teekhasaenee  CRitch  R Glaucoma in phakomatosis pigmentovascularis. Ophthalmology. 1997;104150- 157
Link to Article
Guiglia  MCPrendeville  JS Multiple granular cell tumors associated with giant speckled lentiginous nevus and nevus flammeus in a child. J Am Acad Dermatol. 1991;24359- 363
Link to Article
Tadini  GRestano  LGonzáles-Perez  R  et al.  Phacomatosis pigmentokeratotica: report of new cases and further delineation of the syndrome. Arch Dermatol. 1998;134333- 337
Link to Article
Happle  R Allelic somatic mutations may explain vascular twin nevi. Hum Genet. 1991;86321- 322
Link to Article

Tables

References

Di Landro  ATadini  GLMarchesi  LCainelli  T Phakomatosis pigmentovascularis: a new case with renal angiomas and some considerations about the classification. Pediatr Dermatol. 1999;1625- 30
Link to Article
Du  LCDelaporte  ECatteau  BDestee  APiette  F Phacomatosis pigmentovascularis type II. Eur J Dermatol. 1998;8569- 572
Teekhasaenee  CRitch  R Glaucoma in phakomatosis pigmentovascularis. Ophthalmology. 1997;104150- 157
Link to Article
Guiglia  MCPrendeville  JS Multiple granular cell tumors associated with giant speckled lentiginous nevus and nevus flammeus in a child. J Am Acad Dermatol. 1991;24359- 363
Link to Article
Tadini  GRestano  LGonzáles-Perez  R  et al.  Phacomatosis pigmentokeratotica: report of new cases and further delineation of the syndrome. Arch Dermatol. 1998;134333- 337
Link to Article
Happle  R Allelic somatic mutations may explain vascular twin nevi. Hum Genet. 1991;86321- 322
Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections